drugset
drugset / Trial / NCT04580277

Tofacitinib For Treatment Of Chronic Pouchitis

NCT04580277 ↗

Phase 2 Terminated 6 enrolled Cedars-Sinai Medical Center
NaSingle-groupOpen-labelTreatment

Summary

A phase 2 pilot study to evaluate the effectiveness of tofacitinib in subjects with chronic pouchitis

Timeline

Start
2021-01-25
Primary completion
2022-12-01
Completion
2023-05-15

Drugs

EvaluationDrugModalityDoseRoute
Subject Tofacitinib Small molecule 10 mg Oral

Indications

pouchitis